Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Companies join on eye disease diagnostic:

This article was originally published in Clinica

Executive Summary

Welch Allyn and Applied Spectral Imaging are to jointly develop portable retinal imaging products for the detection of retinal diseases that may lead to blindness. The companies will use Applied's proprietary SpectraCube spectral imaging technology. The technology separates the spectral content of light reacting with retinal tissue to provide a multi-dimensional data base which can be used for image enhancement and analysis. Migdal Ha'emek, Israel-based Applied Spectral will get product development milestones. Welch Allyn, of Skaneateles Falls, New York, will have marketing rights to products resulting from the deal.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT076062

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel